Stroke rates in non-anticoagulated individuals with and without atrial fibrillation and one non-sex CHA2DS2-VASc risk factor: a nationwide registry-based cohort (Atrial Fibrillation in Norway - AFNOR)

27 August 2022 (14:18 - 14:37)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Mariam Anjum

Baerum Hospital, Baerum (Norway)

3 More presentations in this session

Presentation thumbnail

State-of-the-art lecture in Toward better risk stratification for stroke prevention in atrial fibrillation.

Professor G. Lip (Liverpool, GB)

Presentation thumbnail

A synergistic impact of early rhythm control and lifestyle modification on the risk of stroke in patients with new-onset atrial fibrillation: a korean nationwide population-based cohort study

Doctor S. Lee (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Concluding State-Of-the-Art Lecture - How to bridge towards clinical application of novel better risk stratifications for stroke prevention in atrial fibrillation?

Professor T. Potpara (Belgrade, RS)

Access the full session

Session thumbnail

Toward better risk stratification for stroke prevention in atrial fibrillation

The Event

Event poster

ESC Congress 2022

27 August 2022 14:18 CET

You may be interested in

Congress Session

Stroke and bleeding risk in atrial fibrillation: walking the tight rope

Congress Presentation

Arterial thromboembolism in patients with atrial fibrillation and CHA2DS2-VASc score 1: a nationwide study

Congress Presentation

Trends in clinical outcomes of patients with incident atrial fibrillation; results from a nationwide registry

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources